Literature DB >> 15959846

Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells.

K Matsumoto1, Y Akao, H Yi, M Shamoto-Nagai, W Maruyama, M Naoi.   

Abstract

In Alzheimer's disease amyloid beta peptide (Abeta) produced from amyloid precursor protein (APP) is considered to induce cell death. To clarify the molecular mechanism underlying Abeta neurotoxicity, we established the cell line overexpressing wild or mutant (His684Arg) APP in human SH-SY5Y cells. This paper presents that overexpression of wild-APP in the cells (SH/w-APP) increased the levels of APP and Abeta(1-40) but not Abeta(1-42), and reduced Bcl-2 level and proteasome activity with increased susceptibility to oxidative stress. The intracellular levels of reactive oxygen species in SH/w-APP increased significantly by H(2)O(2) treatment. The level of Bcl-2 protein, but not mRNA, was markedly decreased in SH/w-APP cells, which was inversely correlated with APP expression among subcloned SH/w-APP cells. These results indicate that increased expression of wild type APP renders neuronal cells more vulnerable to oxidative stress leading to cell death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15959846     DOI: 10.1007/s00702-005-0318-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

Authors:  C Stadelmann; T L Deckwerth; A Srinivasan; C Bancher; W Brück; K Jellinger; H Lassmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons.

Authors:  E Paradis; H Douillard; M Koutroumanis; C Goodyer; A LeBlanc
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

3.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

Review 4.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

Authors:  D Allan Butterfield; Christopher M Lauderback
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

5.  PDGF receptor-alpha deficiency in glomerular mesangial cells of tenascin-C knockout mice.

Authors:  Kenji Matsumoto; Noriko Hiraiwa; Atsushi Yoshiki; Masatake Ohnishi; Moriaki Kusakabe
Journal:  Biochem Biophys Res Commun       Date:  2002-02-01       Impact factor: 3.575

6.  Impaired proteasome function in Alzheimer's disease.

Authors:  J N Keller; K B Hanni; W R Markesbery
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

7.  N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor.

Authors:  Wakako Maruyama; Atusmi Nitta; Masayo Shamoto-Nagai; Yoko Hirata; Yukihiro Akao; Moussa Yodim; Shoei Furukawa; Toshitaka Nabeshima; Makoto Naoi
Journal:  Neurochem Int       Date:  2004-05       Impact factor: 3.921

Review 8.  Antioxidant treatment in Alzheimer's disease: current state.

Authors:  Yossi Gilgun-Sherki; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines.

Authors:  Kenji Matsumoto; Yukihiro Akao; Emi Kobayashi; Kenji Ohguchi; Tetsuro Ito; Toshiyuki Tanaka; Munekazu Iinuma; Yoshinori Nozawa
Journal:  J Nat Prod       Date:  2003-08       Impact factor: 4.050

View more
  13 in total

1.  Overexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascade.

Authors:  Matthew G Bartley; Kristin Marquardt; Danielle Kirchhof; Heather M Wilkins; David Patterson; Daniel A Linseman
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease.

Authors:  R Derungs; G G Camici; R D Spescha; T Welt; C Tackenberg; C Späni; F Wirth; A Grimm; A Eckert; R M Nitsch; L Kulic
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

Review 3.  Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

Authors:  P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2012-09-17

Review 4.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 5.  Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.

Authors:  P Hemachandra Reddy
Journal:  Exp Neurol       Date:  2009-04-07       Impact factor: 5.330

Review 6.  Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.

Authors:  Latha Devi; Hindupur K Anandatheerthavarada
Journal:  Biochim Biophys Acta       Date:  2009-07-18

7.  The amyloid precursor protein affects glyceraldehyde 3-phosphate dehydrogenase levels, organelle localisation and thermal stability.

Authors:  Alexandré Delport; Stefan Kins; Raymond Hewer
Journal:  Mol Biol Rep       Date:  2020-03-09       Impact factor: 2.316

8.  Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.

Authors:  Maria Manczak; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2012-08-27       Impact factor: 6.150

9.  Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice.

Authors:  Monica Garcia-Alloza; Laura A Borrelli; Bradley T Hyman; Brian J Bacskai
Journal:  Neurobiol Aging       Date:  2009-01-04       Impact factor: 4.673

10.  Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design.

Authors:  Isabel Cardoso; Maria Rosário Almeida; Nelson Ferreira; Gemma Arsequell; Gregorio Valencia; Maria João Saraiva
Journal:  Biochem J       Date:  2007-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.